Immunoglobulin Market Size to Garner USD 24.98 Billion by 2032

The global Immunoglobulin market size was estimated to be around US$ 13.36 billion in 2023. It is projected to reach US$ 24.98 billion by 2032, indicating a CAGR of 7.20% from 2023 to 2032.

Key Takeaways

• North America contributed more than 46% market share in 2022.
• Asia-Pacifica is estimated to witness the fastest CAGR between 2023 and 2032.
• By application, the hypogammaglobulinemia segment has held the largest market share of 38% in 2022.
• By application, the immunodeficiency disease segment is anticipated to grow at a remarkable CAGR of 9.1% between 2023 and 2032.
• By product, the IgA segment generated over 41% of market share in 2022.
• By product, the IgG segment is expected to expand at the fastest CAGR over the projected period.
• By mode of delivery, the Intravenous segment had the largest market share of 66% in 2022.
• By mode of delivery, the subcutaneous segment is expected to expand at the fastest CAGR over the projected period.

The market research report on the Immunoglobulin market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Immunoglobulin products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample: https://www.precedenceresearch.com/sample/3646

Immunoglobulin Market Scope

Read More: Human Augmentation Market Size to Garner USD 1,117.53 Billion by 2032

The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global Immunoglobulin market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Immunoglobulin market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Immunoglobulin products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the Immunoglobulin market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on Immunoglobulin market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Immunoglobulin market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report

Reasons to Purchase this Report:

• Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
• In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
• Market size in USD million and volume in million units provided for each segment and sub-segment.
• Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
• Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Recent Developments

• In 2023, Everest Medicines gained approval from the Hainan Medical Products Administration for clinical use of Nefecon, a primary immunoglobulin A nephropathy (IgAN) drug, in China. This milestone marks progress in addressing IgAN, a condition affecting the kidneys, enhancing treatment options for patients in the region.
• In 2022, Grifols secured approval from European Union member state health authorities and the United Kingdom for XEMBIFY, a groundbreaking 20% subcutaneous immunoglobulin (SCIG). This innovative treatment is authorized for addressing primary and specific secondary immunodeficiency, marking a significant advancement in therapeutic options for these conditions.
• In 2021, Octapharma USA’s investigational new drug (IND) application for a phase three clinical trial assessing the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in severe COVID-19 patients received authorization from the U.S. Food and Drug Administration (FDA).

Immunoglobulin Market Players

• Grifols, S.A.
• Shire
• CSL Behring
• Kedrion S.p.A.
• Octapharma
• Baxter International Inc.
• Biotest AG
• Bio Products Laboratory Ltd. (BPL)
• China Biologic Products Holdings, Inc.
• LFB SA
• Cangene Corporation
• Bharat Serums and Vaccines Limited
• Takeda Pharmaceutical Company Limited
• Bio Products Laboratory Ltd. (BPL)
• China National Pharmaceutical Group Corporation (Sinopharm)

Segments Covered in the Report

By Application

• Hypogammaglobulinemia
• Chronic Inflammatory Demyelinating Polyneuropathy
• Immunodeficiency Disease
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Idiopathic Thrombocytopenic Purpura
• Inflammatory Myopathies
• Specific Antibody Deficiency
• Guillain‐Barré Syndrome
• Others

By Product

• IgA
• IgG
• IgM
• IgE
• IgD

By Mode of Delivery

• Intravenous
• Subcutaneous

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunoglobulin Market 

5.1. COVID-19 Landscape: Immunoglobulin Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunoglobulin Market, By Application

8.1. Immunoglobulin Market, by Application, 2023-2032

8.1.1 Hypogammaglobulinemia

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Chronic Inflammatory Demyelinating Polyneuropathy

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Immunodeficiency Disease

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Myasthenia Gravis

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Multifocal Motor Neuropathy

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Idiopathic Thrombocytopenic Purpura

8.1.6.1. Market Revenue and Forecast (2020-2032)

8.1.7. Inflammatory Myopathies

8.1.7.1. Market Revenue and Forecast (2020-2032)

8.1.8. Specific Antibody Deficiency

8.1.8.1. Market Revenue and Forecast (2020-2032)

8.1.9. Guillain Barre Syndrome

8.1.9.1. Market Revenue and Forecast (2020-2032)

8.1.10. Others

8.1.10.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Immunoglobulin Market, By Product

9.1. Immunoglobulin Market, by Product, 2023-2032

9.1.1. IgA

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. IgG

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. IgM

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. IgE

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. IgD

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Immunoglobulin Market, By Mode of Delivery 

10.1. Immunoglobulin Market, by Mode of Delivery, 2023-2032

10.1.1. Intravenous

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Subcutaneous

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Immunoglobulin Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

Chapter 12. Company Profiles

12.1. Grifols, S.A.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Shire

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. CSL Behring

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Kedrion S.p.A.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Octapharma

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Baxter International Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Biotest AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Bio Products Laboratory Ltd. (BPL)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. China Biologic Products Holdings, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. LFB SA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/